VRXA MEXC RealStocks
Own real VRXA shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 07:11:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Veraxa Biotech AG (VRXA) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.03, with a market capitalization of $147.06M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.90 to $27.36. This page covers its latest market performance, valuation, price trends and company information.
$147.06M | |
$1.04 | |
$1.06 | |
$1.03 | |
$1.04 | |
99.42K | |
270.05K | |
-- | |
$27.36 | |
$0.90 | |
-- | |
-- |
Veraxa Biotech AG (VRXA) last closed at $1.03 as of 2026-11-19 00:45:00, down 0.87% ($0.01) from the previous close of $1.04.
During the latest regular trading session, VRXA traded between $1.03 and $1.06, with a volume of 99.42K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Veraxa Biotech AG (VRXA) moved from $1.07 to $1.03, representing a decline of 3.64% ($0.04).
The stock traded between $1.00 and $1.33 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 132.14 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.5%
VRXA is currently trading at $1.03, placing it 0.5% of the way from its 52-week low of $0.90 to its 52-week high of $27.36. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Veraxa Biotech AG (VRXA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to VRXA, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between VRXA shares and USD.
VRXA Shares to USD
1.00 VRXA shares = 1.031 USD
Calculations are estimates based on the latest available price and are for reference only.